亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會(huì)員登錄|免費(fèi)注冊(cè)|忘記密碼|管理入口 返回主站||保存桌面|手機(jī)瀏覽|聯(lián)系方式|購物車
企業(yè)會(huì)員第1年

杭州榮大醫(yī)藥化工有限公司  

全球供應(yīng):阿那曲唑、拉帕替尼、伊班膦酸鈉、氟維司群、恩替卡韋、鹽酸帕洛諾司瓊、頭孢噻呋鈉、雙咪唑、3-羥基苯乙酮、二甲磺酸乙胺鹽酸鹽、N-[3-氯-4-(3-氟芐氧基)苯基]-6-碘-4-喹唑啉胺、3-N-甲基正戊胺基丙酸鹽酸鹽

搜索
新聞中心
  • 暫無新聞
產(chǎn)品分類
  • 暫無分類
聯(lián)系方式
  • 聯(lián)系人:趙陽
  • 電話:0571-28281885
  • 郵件:sunnie@rdpharm.com
  • 傳真:0571-28281887
  • QQ:296932225
站內(nèi)搜索
 
榮譽(yù)資質(zhì)
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應(yīng)產(chǎn)品 > 供應(yīng) 氟維司群
供應(yīng) 氟維司群
單價(jià) 面議對(duì)比
詢價(jià) 暫無
發(fā)貨 浙江杭州市付款后3天內(nèi)
型號(hào) 129453-61-8
規(guī)格 99%
過期 長(zhǎng)期有效
更新 2013-04-16 16:23
 
詳細(xì)信息

氟維司群
英文名: Fulvstrant
CAS No.: 129453-61-8
規(guī)格:  99%
外觀:  白色粉末
包裝:  鋁箔袋+紙板箱
結(jié)構(gòu)式:
©2025 杭州榮大醫(yī)藥化工有限公司 版權(quán)所有   技術(shù)支持:化工網(wǎng)   訪問量:25971  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |